egfr mutation-induced alternative splicing of max contributes to growth of glycolytic tumors in...

EGFR Mutation-Induced Alternative Splicing of Max Contributes to Growth of Glycolytic Tumors in Brain Cancer 

Ivan Babic, Erik S. Anderson, Kazuhiro Tanaka, Deliang Guo, Kenta Masui, Bing Li, Shaojun Zhu, Yuchao Gu, Genaro R. Villa, David Akhavan, David Nathanson, Beatrice Gini, Sergey Mareninov, Rui Li, Carolina Espindola Camacho, Siavash K. Kurdistani, Ascia Eskin,

Stanley F. Nelson, William H. Yong, Webster K. Cavenee, Timothy F. Cloughesy, Heather R. Christofk, Douglas L. Black, Paul S. Mischel 

Cell Metabolism Volume 17, Issue 6, Pages 1000-1008 (June 2013)

DOI: 10.1016/j.cmet.2013.04.013

Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 1

Cell Metabolism 2013 17, 1000-1008DOI: (10.1016/j.cmet.2013.04.013) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 2

Cell Metabolism 2013 17, 1000-1008DOI: (10.1016/j.cmet.2013.04.013) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 3

Cell Metabolism 2013 17, 1000-1008DOI: (10.1016/j.cmet.2013.04.013) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 4

Cell Metabolism 2013 17, 1000-1008DOI: (10.1016/j.cmet.2013.04.013) Copyright © 2013 Elsevier Inc. Terms and Conditions

Cell Metabolism 2013 17, 1000-1008DOI: (10.1016/j.cmet.2013.04.013) Copyright © 2013 Elsevier Inc. Terms and Conditions